Physician profile

Rakesh Prashad

Interventional Cardiology · Ocala, FL

NPI 1992800155

$16,388.67

in general payments reported to CMS, 2019-2025

52 companies · $3,755 in 2025

The $3,755 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$5,015.14
Food and Beverage$4,998.84
Education$10.85

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $5,512.72 2019-2025 Versacross Access Solution, General - Therapies, General - Tachy
Medtronic, INC. $2,311.52 2021-2024 Micra, Azure Xt Dr Mri Surescan
Medtronic Vascular, INC. $1,476.80 2019-2020
Penumbra, INC. $1,096.16 2019
Abbott Laboratories $583.31 2019-2025 Aveir, Jot Dx, Assurity
Amgen INC. $451.22 2019-2025 Evenity, Repatha, Repatha
Edwards Lifesciences Corporation $387.30 2022-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Janssen Pharmaceuticals, INC $365.04 2019-2022
Pfizer INC. $344.77 2022-2025
Novartis Pharmaceuticals Corporation $309.36 2019-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $264.90 2019-2025 Lifevest
Esperion Therapeutics, INC. $256.94 2020-2024 Nexletol
Impulse Dynamics (USA) INC. $244.69 2022-2025 Optimizer, Optimizer
Abiomed $243.12 2020-2024 Impella
Alnylam Pharmaceuticals INC. $226.22 2022-2025 Amvuttra, Onpattro
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $220.53 2020-2025 Jardiance
Merck Sharp & Dohme LLC $207.31 2021-2025 Verquvo
Cardiva Medical, INC. $203.76 2021-2024 Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs, Optowire
Biosense Webster, INC. $171.17 2025 Carto 3, Qdot Micro, Nuvision Ice Catheter
Astrazeneca Pharmaceuticals LP $164.80 2019-2025 Farxiga, Brilinta
Eisai INC. $124.88 2025
Stryker Corporation $124.78 2021
Idorsia Pharmaceuticals US INC $124.51 2023 Quviviq
Amarin Pharma, INC. $113.59 2019-2022
E.R. Squibb & Sons, L.L.C. $94.83 2020-2025 Camzyos, Eliquis
Novo Nordisk INC $56.26 2021-2022
Sanofi-Aventis U.S. LLC $55.91 2019-2024
Bardy Diagnostics, INC. $54.50 2020-2022
Ge Healthcare $52.14 2023
Philips North America LLC $51.38 2020
Astellas Pharma US INC $48.13 2021
Medicomp INC $39.30 2023 Telepatch Cardiac Monitor
Tactile Systems Technology INC $38.67 2020-2025 Flexitouch Plus, Nimbl
Welch Allyn $38.13 2021
Innovation Technologies INC $34.44 2025 Irrisept
United Therapeutics Corporation $32.53 2025 Tyvaso
Cmp Pharma, INC. $29.88 2023 Norliqva, Carospir, Atorvaliq
Biotronik INC. $26.81 2024 Biomonitor
Akcea Therapeutics, INC. $26.07 2020
Glaxosmithkline, LLC. $24.39 2025 Shingrix
Cvrx, INC. $23.67 2024 Barostim Neo System
Organogenesis INC. $20.78 2020
Elutia, INC. $20.47 2024 Ecm Patch,Pouch
Bayer Healthcare Pharmaceuticals INC. $19.04 2023
Actelion Pharmaceuticals US, INC. $18.97 2023 Uptravi, Opsumit
Lexicon Pharmaceuticals, INC. $16.38 2023 Inpefa
Lundbeck LLC $16.17 2019
Arbor Pharmaceuticals, INC. $14.40 2021
G Medical Diagnostic Services, INC. $6.02 2019

3 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rakesh Prashad

$16,388.67

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $3,755 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/226049/rakesh-prashad

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.